retatrutide triple agonist glp-1 gip glucagon ly3437943 Retatrutide's mechanisms of action Synedica Retatrutide | Triple Agonist

Beyond diabetes and weight management, these medications offer cardioprotection, neuroprotection, anti-inflammatory benefits, and potentially improved longevity

Are there other risks

When to contact your GP or diabetes team : Persistent vomiting preventing fluid intake Severe abdominal pain, especially if radiating to the back (possible pancreatitis) Right upper abdominal pain, fever or jaundice (possible gallbladder problems) Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained hypoglycaemia if on combination therapy New or worsening visual symptoms (especially if you have diabetic retinopathy) Allergic reactions (rash, swelling, breathing difficulties) Most patients tolerate GLP-1 medications well once past the initial adjustment period

Archived from the original on 28 January 2023

cholesterol metabolism and lipid-mediated signaling